Marinus Pharmaceuticals Inc (MRNS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MRNS Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Marinus Pharmaceuticals Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent42.18
Cash, Cash Equivalents Other0.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments42.00
Accounts receivable3.84
Other Receivables0.00
Inventories6.72
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.66
Total Current Assets57.40
Equipment/Property/Plant Net4.88
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.34
Total Assets63.62
Liabilities
Accounts Payable, Current AC3.71
Accrued Liabilities, Current AC14.16
Notes Payable, Current NO13.48
Total Current Liabilities34.50
Long-term debt41.71
Total Long-term Debt41.71
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent54.15
Revenue Interest Financing Payable Current3.16
Contract With Customer Contract Liability Net Of Contract Asset18.11
Total Liabilities130.36
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock603.85
Retained Earnings / Accumulated Deficit-670.65
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-66.74
Total Stockholder's Equity-66.74
Liabilities & Stockholder's Equity63.62
4 historic quarters locked

Sign in to unlock the full Marinus Pharmaceuticals Inc balance sheet history.

About Marinus Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-24-015315

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.